Truist upgraded Inspire Medical (INSP) to Buy from Hold with a price target of $165, up from $128.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Brinker upgraded, Coinbase downgraded: Wall Street’s top analyst calls
- Wolfe upgrades Inspire on ‘surprise’ Medicare reimbursement raise
- Inspire Medical upgraded to Outperform from Peer Perform at Wolfe Research
- Inspire Medical Systems: Balancing Positive Reimbursement Developments with Market Uncertainties
- Inspire Medical price target raised to $128 from $84 at Truist